清热通督汤治疗强直性脊柱炎的临床的研究.pdf

标的改善作用均优于柳氮磺胺吡啶。 关键词 强直性脊柱炎 清热通督汤 临床研究 The clinical study of Qingretongdutang On Ankylosing Spondylitis Speciality:Internal Medicine of T.C.M Rheumatic Disease Author:Liu Xiaobo Tutor:Professor Sun Suping Abstract Objective: a specific syndrome of ankylosing spondylitis patients as test subjects to sulfasalazine as control the use of drugs, the use of the international ASAS working group to develop the ASAS20, BASDAI50 standards and efficacy of traditional Chinese medicine symptom criteria, the evaluation in order to heat and dampness, removing blood stasis collaterals to the principles of clinical experience prescriptions side Qingretongdutang treating ankylosing spondylitis patients with the clinical efficacy of stasis type.Methods: This study used a randomized, positive for drugs, parallel controlled clinical evaluation. Drug program: Chinese Test group: Treating prescription by agreement, one day, decoction 300ml, oral, morning and evening. Comparison group: oral administration of sulfasalazine, the first week: 0.25g, bid; the second week: 0.5g, bid; third week: 0.75, bid; the fourth week onwards: 1.0g, bid. Treatment for 6 months. Grouping method: According to the random number table method will be included in rate cases are grouped, in which experimental group of 30 patients in the control group of 30 patients.Clinical observation: clinical symptoms and the symptoms, Bath Ankylosing Spondylitis Metrology Index (BASMI), including cervical rotation, tragus - the wall from the other, Bath ankylosing spondylitis disease activity index survey (BADSDAI), Bath ankylosing spondylitis functional Index Questionnaire (BATHFI),